Objective To compare the efficacy and safety of a concentrated formulation of insulin glargine (Gla-300) with other basal insulin therapies in patients with type 2 diabetes mellitus (T2DM). Design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results